Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06598072Phase 3Completed
Phase 3, randomised, double-blind trial of cetylpyridinium chloride + zinc lactate + sodium fluoride in gingivitis and dental plaque (3 arms), sponsored by Colgate-Palmolive. Primary endpoint: Modified Gingival Index at 12 weeks. Started Sep 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06598072.